BioHealth News Archive
Oxitec, a subsidiary of Germantown, MD based Intrexon, is working to fight mosquito born illnesses
Most people consider mosquitoes to be a summertime pest – the unwelcome guest at the backyard barbecue. More concerning are the threats from disease-carrying…
Read MoreAdventist HealthCare names new Shady Grove Medical Center leader – Washington Business Journal
The new president first joined the Rockville hospital's leadership team in 2011. {iframe}https://www.bizjournals.com/washington/news/2019/09/11/adventist-healthcare-names-new-shady-grove.html?ana=e_mc_prem&j=83777361&t=Morning&mkt_tok=eyJpIjoiWWpGbFpqa3hNakV6T1dRMSIsInQiOiJPdHR5ZFd3SzJxZFVIZGRrZUg3ZTRTTEt5TlhZa1FZaDhJdkdSUUZhdjI0ekRKZW1vaHc0aEdKNTVQRnJsYXJpbGdSQTE2ZGxcL3BwdkJWZ1ZYZWpcL0ZHNm5lK0xSMVVcL0pwV1V5cGQ2R3RKWUd0bUFOUEdzcHhBUDM4MlBrdndqbyJ9{/iframe}
Read MoreLockheed Donates $3 Million to University of Maryland STEM Program
Lockheed Martin recently signed a $3 million charitable commitment to the University of Maryland A. James Clark School of Engineering. The three-year contribution will…
Read MoreCity Business Leaders Hail Perman’s Leadership – University of Maryland, Baltimore
“I think most of you know how deeply I care for this city and its people, how much I love being part of a…
Read MoreUSM investment fund has tapped mostly Baltimore, College Park startups – Maryland Daily Record
The Maryland Momentum Fund has been successful in its first couple of years but needs to do a better job of marketing itself to…
Read MoreInfographic: Which Rare Diseases Are The Most Common?
Pharmaceuticals have come a long way since the apothecary days of prescribing cocaine drops for toothaches, or dispensing tapeworm diet pills. {iframe}https://www.visualcapitalist.com/which-rare-diseases-are-the-most-common/{/iframe}
Read MoreUSM is investing $250k in a product designed to heal skin wounds – The Diamondback
The University System of Maryland recently invested $250,000 in a University of Maryland alumna’s biotech company. {iframe}https://dbknews.com/2019/09/11/umd-invest-gemstone-biotech-usm/{/iframe}
Read MoreRegenxBio reaches licensing deal with Clearside Biomedical – Washington Business Journal
RegenxBio Inc. just locked in another deal — this one with a company working to treat eye diseases. The Rockville biotech has reached a…
Read MoreFDA Approval of Roche Cancer Drug Confirms Beginning of New Oncology Era | The Motley Fool
With nothing more than a passing glance, the U.S. Food & Drug Administration's (FDA) approval of Roche Holdings' (OTC:RHHBY) cancer drug entrectinib last month…
Read MoreFirst hint that body’s ‘biological age’ can be reversed
A small clinical study in California has suggested for the first time that it might be possible to reverse the body’s epigenetic clock, which…
Read MoreBaltimore-based Capsulomics wins first place at Patriot Boot Camp in Utah – Technical.ly Baltimore
Baltimore-based Capsulomics won the top award in Utah last month at a pitch competition that was part of a boot camp for early-stage companies…
Read MoreMaryland Startup Developing AI-Enabled Drug Discovery Technology, Insilico Medicine, Just Raised $37M in Funding from Leading Chinese VC Firm · BioBuzz
In the world of drug discovery and development, there is increasing pressure to get novel products to market faster, cheaper and ahead of the…
Read MoreWhat Does It Take to Build A Globally Competitive Biohealth Cluster? · BioBuzz
The BioHealth Capital Region (BHCR) continues to thrive and currently occupies the fourth spot in the most recent Genetic Engineering & Biotechnology (GEN) top…
Read MoreUnited Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review
United Therapeutics Corporation (UTHR) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for…
Read MoreHow Top Companies Attract, Engage and Retain Their BioHealth Workforce · BioBuzz
Are you finding it harder to recruit, hire and retain the biotech workforce you need? Well, you’re not alone. With the demand for talent at…
Read More